HopeStage
Back to all studies
RecruitingNCT06266715

ATP or saline added to escitalopram for depression

About this titleRead the official source — NCT06266715
Medication studyAges 18–65China
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
GuangzhouSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 4, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
120
Sponsor
Nanfang Hospital, Southern Medical University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT06266715
Official title
Show the full official title

A Double-blind Randomized Controlled Trial of Adenosine Disodium Triphosphate in Improving Moderate to Severe Depressions

Recruitment & locations

Currently recruiting

Guangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nanfang Hospital, Southern Medical University, a university.

Does this study involve medication?

Yes. The study involves medication, including ATP Group.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies